FDA Recalls Finder

FDA Approves Botox to Treat Spasticity in Flexor Muscles of the Elbow, Wrist and Fingers
9 March 2010, 3:42 pm

The U.S. Food and Drug Administration today approved Botox (onabotulinumtoxin A) to treat spasticity in the flexor muscles of the elbow, wrist, and fingers in adults. Spasticity is common after stroke, traumatic brain injury, or the progression of multiple sclerosis.

Source: Food and Drug Administration--Press Releases